Stefan H. Blaas
Franz Josef Strauss Allee 11
Regensburg, BY 93053, Germany
Regensburg, BY 93053, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications
Hyper-reactivity of CD8+ T cells and high expression of IL-3 correlates with occurrence and severity of Long-COVID.
Journal: Clinical immunology (Orlando, Fla.)
Published: April 02, 2025
Negative impact of face masks in patients with interstitial lung disease: A prospective study.
Journal: Pneumologie (Stuttgart, Germany)
Published: July 30, 2024
Whole-genome sequencing reveals two prolonged simultaneous outbreaks involving Pseudomonas aeruginosa high-risk strains ST111 and ST235 with resistance to quaternary ammonium compounds.
Journal: The Journal of hospital infection
Published: October 23, 2023
Rare cause of necrotizing pneumonia : A case report
Journal: Innere Medizin (Heidelberg, Germany)
Published: April 25, 2023
Scorpionfish BPI is highly active against multiple drug-resistant Pseudomonas aeruginosa isolates from people with cystic fibrosis.
Journal: eLife
Published: January 21, 2023
Performance of T-Track® TB, a Novel Dual Marker RT-qPCR-Based Whole-Blood Test for Improved Detection of Active Tuberculosis.
Journal: Diagnostics (Basel, Switzerland)
Published: January 19, 2023
Head-to-Head Comparison of Dual-Source and Split-Beam Filter Multi-Energy CT versus SPECT/CT for Assessing Lobar Lung Perfusion in Emphysema.
Journal: Radiology. Cardiothoracic imaging
Published: November 07, 2022
Rasmussen Aneurysm: A Forgotten Complication.
Journal: American journal of respiratory and critical care medicine
Published: September 12, 2022
Cardiopulmonary exercise pattern in patients with persistent dyspnoea after recovery from COVID-19.
Journal: Multidisciplinary respiratory medicine
Published: November 01, 2020
Lipopolysaccharide Binding Protein and Bactericidal/Permeability-Increasing Protein as Biomarkers for Invasive Pulmonary Aspergillosis.
Journal: Journal of fungi (Basel, Switzerland)
Published: October 13, 2020
Pirfenidone in patients with progressive fibrotic interstitial lung diseases other than idiopathic pulmonary fibrosis (RELIEF): a double-blind, randomised, placebo-controlled, phase 2b trial.
Journal: The Lancet. Respiratory medicine
Published: February 21, 2020
Last Updated: 09/26/2026